MY ACCOUNT | NEWSLETTER |

Effects of fecal microbiota transplantation in dogs with chronic enteropathies


Chronic enteropathy is common in dogs, but not all dogs will respond satisfactorily to standard treatment. A few case reports suggest that fecal microbiota transplantation (FMT) can be used in dogs if standard treatments fail.

Here, the authors report the effects of fecal microbiota transplantations in 41 dogs with chronic enteropathy, with a follow-up time of 3–41 months.

None of the dogs had previously responded satisfactorily to standard treatment. Most dogs received three FMT treatments with 10–20 days’ interval in between.

The treatment was given in parallel with the maintenance medical treatment and diet the dog was already being treated with. After treatment, 31/41 dogs had decreased clinical signs, with most dogs showing less diarrhea and/or becoming more active.

From 16 dogs, fecal samples were taken before the first FMT. Dogs with a more severe dysbiosis, as indicated by a severely increased fecal dysbiosis index, responded more poorly to FMT compared to those dogs with milder form of dysbiosis.

The study supports previous case reports that fecal microbiota transplantation can be useful as an adjunct to the standard treatment of dogs with chronic enteropathy.

Toresson L, Spillmann T, Pilla R, Ludvigsson U, Hellgren J, Olmedal G, Suchodolski JS. "Clinical Effects of Faecal Microbiota Transplantation as Adjunctive Therapy in Dogs with Chronic Enteropathies—A Retrospective Case Series of 41 Dogs." Veterinary Sciences. 2023; 10(4):271. https://doi.org/10.3390/vetsci10040271

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity

Like0
Dislike0

Canine and Human Dirofilariosis in the Rostov Region (Southern Russia)

Like0
Dislike0

Infrared thermography: Current applications in equine medicine

Like0
Dislike0

Deadly pathogens found in commercial raw cat foods

Like0
Dislike0

Famous Online, Delicious IRL: Woof Gang Launches Iconic Dog Treat Collab

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top